The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy

👀 Did you know that approximately 60%–70% of patients with malignant tumours require radiotherapy? Research on how to improve radiotherapy efficacy using PD-1/PD-L1 inhibitor is gaining momentum. Read more 👉 https://t.co/Zt0iHOx1MQ #FLASHrt #Medphys #F

New research: The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy: Approximately 60%–70% of patients with malignant tumours require radiotherapy. The clinical application of immune checkpoint inhibitors (ICIs), such… https://t.co